Patent GB-1009288-A (GB)
Title: Naphthalene compounds and methods for their production
IPC: C07C17/32
Filed: 1964-05-01
Abstract: The invention comprises compounds of the formula <FORM:1009288/C2/1> wherein R is hydrogen, a salt-forming cation, a lower alkyl radical or a lower dialkylaminoalkyl group, R2 is hydrogen or methyl and one of R3 and R4 represents hydrogen and the other represents a phenyl group optionally bearing a fluorine, chlorine, bromine, o-methyl, m-methyl, o-methoxy or m-methoxy substituent (the term "lower" indicating that the alkyl radicals have 1-4 carbon atoms and alkylene groups up to 4 carbon atoms, separating the groups to which they are attached by at least 2 carbon atoms).  The compounds are prepared by (a) hydrolysing a 1-methyl or 1-ethyl naphthalene bearing an appropriate hydrolysable substituent in the a -position such as a cyano, esterified carboxyl, carbamoyl, alkyl-substituted carbamoyl, trihalomethyl, amidino, haloformyl, -CO.NHNH2, -CO.NHOH, -C(:NOH)NH2, -C(:NH).NHNH2, -C(:NH) halogen or -CO.C(halogen)3 group, to give a compound in which R is hydrogen or a salt-forming cation; (b) reacting the metal derivative of a 1-methyl- or 1-ethyl-naphthalene, e.g. an a -lithium derivative or an a -magnesium halide with carbon dioxide in an anhydrous medium and acidifying the product to give a compound in which R is hydrogen, and (c) esterifying the free acid or a reactive derivative thereof with a lower alkanol or lower dialkylaminoalkanol or a reactive derivative thereof to give a product wherein R is lower alkyl or lower dialkylaminoalkyl. The acids form salts with bases such as alkali-metals, ammonia, diethylamine, choline and 2-hydroxyethylamine. The basic compounds of the invention form salts with inorganic and organic acids.  Phenyl - substituted - naphthalene - 1 - aceto - nitriles used as starting materials, are made by reacting a corresponding phenyl-substituted-1-chloromethylnaphthalene (obtained by reaction of a phenylnaphthalene with formaldehyde and HCl) or a phenyl - substituted - 1 - bromomethylnaphthalene (obtained by brominating a phenyl-substituted - 1 - methyl - naphthalene with N-bromosuccinnide) with sodium cyanide.  Phenyl - substituted - 1 - methyl - naphthalenes in which the phenyl group may bear substituents corresponding to Z, are made by treating a 1 - oxo - 4 - methyl - 1,2,3,4 - tetrahydronaphthalene with the appropriate phenyl magnesium halide and dehydrogenating the resulting phenyl - substituted - 1 - oxo - 4 - methyl - 1,2 - dihydronaphthalene by heating it with sulphur.  Methyl a  - methyl - 4 - phenyl - 1 - naphthaleneacetate is made by esterifying 4-phenyl-1-naphthaleneacetic acid with methanol, reacting the resulting ester with sodium hydride in dimethyl sulphoxide and methylating the resulting solution with methyl iodide. 4 - Phenyl - 1 - naphthylacetimidic acid ethyl ester hydrobromide is made by reacting 4-phenyl-1-naphthylacetonitrile with hydrogen bromide in ethanol.  4 - Phenyl - 1 - naphthaleneacetic hydrazide is made by reacting the acid with hydrazine hydrate.  4 - Phenyl - 1 - naphthaleneacetamide is made by refluxing 4-phenyl-1-naphthaleneacetimidic acid ethyl ester hydrobromide in acetone.  4 - Phenyl - 1 - naphthaleneacetyl chloride is made by reacting the free acid with thionyl chloride.  4 - Phenyl - 1 - naphthaleneacetic anhydride is made by reaction between the chloride of the acid and its sodium salt.  1 - m - Chlorophenyl - naphthalene is made by reacting the monomagnesium derivative of 3-chlorobromobenzene with 1-oxo-1,2,3,4-tetrahydronaphthalene, hydrolysing the reaction product to give 4-(m-chlorophenyl)-1,2-dihydronaphthalene and dehydrogenating this by heating with sulphur.  4 - Phenyl - 1 - naphthaleneacetamidine is made by the action of ammonium chloride on 4-phenyl-1-naphthaleneacetimidic acid ethyl ester.  Pharmaceutical preparations having anti-inflammatory activity comprise the above compounds of the invention, with a carrier or diluent, in pharmaceutical forms such as tablets, capsules, powders, solutions and suspensions, preferably in a form suitable for oral administration.